Opportunity
DIBBS #SPE2DP-26-T-2386
DLA Solicitation for Hydrochlorothiazide Tablets, USP, 25 mg (100 Tablets)
March 25, 2026
March 30, 2026
SPE2DP-26-T-2386
424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain's request for Hydrochlorothiazide Tablets, USP, 25 mg, in bottles of 100 tablets, for delivery to a federal facility. - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharm FSA - Contracting office at 700 Robbins Avenue, Philadelphia, PA 19111 - OEMs and Vendors: - Golden State Medical Supply, Inc. (NDC51407-0331-01) - Teva Pharmaceuticals USA, Inc. (NDC00172-2083-60) - Additional approved source (NDC69315-0131-01) - Products Requested: - Hydrochlorothiazide Tablets, USP, 25 mg, bottle of 100 tablets - NSN: 6505-01-554-4306 - Quantity: 1 unit - RX only, shelf life 24 months (non-extendable) - Packaging and marking per Medical Marking Standard No. 1 - Unique or Notable Requirements: - Compliance with Buy American Act - NIST SP 800-171 cybersecurity assessment required - Hazardous material labeling requirements - Delivery required within 5 days of award, FOB destination - Delivery location: USNS Bruce C Heezen (T-AGS 64), FPO AP 96667
Description
HYDROCHLOROTHIAZIDE (QTY: 1, NSN: 6505-01-554-4306, Purchase Request: 7016017090) Approved Sources: - CAGE: 1HT23, Part No: NDC51407-0331-01, Company: GOLDEN STATE MEDICAL SUPPLY, INC. - CAGE: 3V8D7, Part No: NDC00172-2083-60, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 7EP57, Part No: NDC69315-0131-01